GSA Capital Partners’s Larimar Therapeutics LRMR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-102,039	Closed	-$389K	–	1975
2025 Q4	$389K	Buy	102,039 +20,633	+25%	+$80.2K	0.03%	986
2025 Q3	$263K	Sell	81,406 -18,516	-19%	-$69.4K	0.02%	1274
2025 Q2	$289K	Buy	+99,922	New	+$231K	0.02%	1278
2025 Q1	–	Sell	-148,533	Closed	-$575K	–	1901
2024 Q4	$575K	Buy	148,533 +41,125	+38%	+$271K	0.04%	782
2024 Q3	$704K	Buy	107,408 +55,984	+109%	+$450K	0.05%	682
2024 Q2	$373K	Buy	51,424 +22,362	+77%	+$171K	0.03%	1147
2024 Q1	$221K	Buy	29,062 +3,830	+15%	+$29.8K	0.02%	1364
2023 Q4	$115K	Sell	25,232 -63,981	-72%	-$216K	0.01%	1384
2023 Q3	$352K	Buy	89,213 +33,392	+60%	+$126K	0.03%	993
2023 Q2	$175K	Buy	55,821 +45,029	+417%	+$184K	0.02%	1307
2023 Q1	$49K	Buy	+10,792	New	+$56.4K	﹤0.01%	1400
2019 Q3	–	Sell	-881	Closed	-$13K	–	1566
2019 Q2	$13K	Sell	881 -1,367	-61%	-$36.4K	﹤0.01%	1396
2019 Q1	$74K	Sell	2,248 -3,501	-61%	-$179K	0.01%	1351
2018 Q4	$341K	Buy	+5,749	New	+$568K	0.04%	765
2017 Q3	–	Sell	-6,142	Closed	-$259K	–	1780
2017 Q2	$259K	Buy	+6,142	New	+$314K	0.02%	1363